EQS-News: Mayr-Melnhof Karton AG
/ Key word(s): Mergers & Acquisitions
MM Packaging becomes a global player in secondary Healthcare & Pharma packaging The Mayr-Melnhof Group (MM) has successfully finalized the acquisition of Essentra Packaging which was agreed in June 2022, after receiving approval from all relevant competition authorities. The transaction comprises of 100% of the shares in ESNT Packaging & Securing Solutions Limited (UK) and 100% of the shares in Essentra Packaging US Inc (US) as well as their affiliated companies. Through this acquisition, MM Packaging expands its cartons, leaflets and labels activities for the resilient and profitable Healthcare & Pharma market creating an attractive platform for further growth. Essentra Packaging has 21 manufacturing sites in 10 countries throughout Europe, US Mainland and Puerto Rico ideally complementing MM Packaging’s current position in pharma packaging in the Nordics and France. Essentra Packaging employs about 3,500 people and reported 2021 sales of c. GBP 370 million (currently approx. EUR 410 million). Peter Oswald, CEO of MM Group, highlights, “Essentra Packaging is a game-changer for us, positioning MM as a global player in secondary pharma packaging, enabling more innovation and more investment in sustainability. We have identified attractive synergies and upside potential which we will leverage through the integration. Together with the team of Essentra Packaging we are fully geared to shape the future of pharma packaging.”
02.10.2022 CET/CEST This Corporate News was distributed by EQS Group AG. www.eqs.com |
Language: | English |
Company: | Mayr-Melnhof Karton AG |
Brahmsplatz 6 | |
1040 Wien | |
Austria | |
Phone: | 0043 1 501 36 91180 |
Fax: | 0043 1 501 36 91391 |
E-mail: | investor.relations@mm.group |
Internet: | www.mm.group |
ISIN: | AT0000938204 |
WKN: | 93820 |
Indices: | ATX |
Listed: | Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Munich, Stuttgart; Vienna Stock Exchange (Official Market) |
EQS News ID: | 1454135 |
End of News | EQS News Service |
|
1454135 02.10.2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.